Home LiteratureArticle Details
PMID: 6339378 Published · ppublish English Comparative Study Journal Article Research Support, Non-U.S. Gov't

Peroral immunization of rats with Escherichia coli heat-labile enterotoxin delivered by microspheres.

Infection and immunity ·Vol. 39 ·No. 2 ·1983-02-00 ·Pages 1000-3

Klipstein FA, Engert RF, Sherman WT

Abstract

The antigenicity of the Escherichia coli heat-labile enterotoxin was not protected against the adverse effect of gastric acidity when the toxin was given together with bicarbonate for peroral immunization to rats, but immunization with the heat-labile enterotoxin encapsulated in pH-dependent microspheres aroused the same strong degree of serum and mucosal antitoxin responses and of protection against challenge as was achieved by peroral immunization after ablation of gastric secretions by pretreatment with cimetidine.

MeSH Terms
Administration, Oral Animals Antitoxins/analysis Bacterial Toxins Bicarbonates/pharmacology Cimetidine/pharmacology Enterotoxins/immunology Escherichia coli Infections/prevention & control Escherichia coli Proteins Immunization/methods Immunization, Secondary Microspheres Rats Rats, Inbred Strains
Chemicals
Antitoxins Bacterial Toxins Bicarbonates Enterotoxins Escherichia coli Proteins heat stable toxin (E coli) Cimetidine
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Klipstein F A
Engert R F
Sherman W T
References (12)
12 references, click to expand
  1. Isolation and characterization of homogeneous heat-labile enterotoxins with high specific activity from Escherichia coli cultures.
    Infect Immun. 1979 Jun;24(3):760-9 PMID: 89088
  2. Protective effect of active immunization with purified Escherichia coli heat-labile enterotoxin in rats.
    Infect Immun. 1979 Mar;23(3):592-9 PMID: 378831
  3. Induction of a mucosal antitoxin response and its role in immunity to experimental canine cholera.
    Infect Immun. 1978 Jul;21(1):185-93 PMID: 711314
  4. Antigenicity of purified glutaraldehyde-treated cholera toxoid administered orally.
    Infect Immun. 1978 Jul;21(1):158-62 PMID: 101456
  5. Immunity to experimental cholera. III. Enhanced duration of protection after sequential parenteral-oral administration of toxoid to dogs.
    J Infect Dis. 1977 Jun;135(6):888-96 PMID: 864285
  6. Arousal of mucosal secretory immunoglobulin A antitoxin in rats immunized with Escherichia coli heat-labile enterotoxin.
    Infect Immun. 1982 Sep;37(3):1086-92 PMID: 7129629
  7. Influence of route of administration on immediate and extended protection in rats immunized with Escherichia coli heart-labile enterotoxin.
    Infect Immun. 1980 Jan;27(1):81-6 PMID: 6987180
  8. Protective effect of immunization of rats with holotoxin or B subunit of Escherichia coli heat-labile enterotoxin.
    Infect Immun. 1981 Jan;31(1):144-50 PMID: 7011990
  9. Comparative study of varying regimens to improve steatorrhoea and creatorrhoea in cystic fibrosis: Effectiveness of an enteric-coated preparation with and without antacids and cimetidine.
    Lancet. 1981 Nov 14;2(8255):1071-4 PMID: 6118524
  10. Intestinal antibody responses after immunisation with cholera B subunit.
    Lancet. 1982 Feb 6;1(8267):305-8 PMID: 6120313
  11. Development of a vaccine of cross-linked heat-stable and heat-labile enterotoxins that protects against Escherichia coli producing either enterotoxin.
    Infect Immun. 1982 Aug;37(2):550-7 PMID: 6749682
  12. An enteric-coated pancreatic enzyme preparation that works.
    Dig Dis Sci. 1979 Dec;24(12):906-9 PMID: 510089
Article Info
Journal
Infection and immunity
Abbr.
Infect Immun
ISSN
0019-9567
Published
1983-02-00
Pages
1000-3
Language
English
Region
United States
NLM ID
0246127
PMCID
PMC348049
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com